These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31415917)

  • 1. Biologics in Sjögren's syndrome.
    Skarlis C; Marketos N; Mavragani CP
    Pharmacol Res; 2019 Sep; 147():104389. PubMed ID: 31415917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Sjögren's syndrome: current therapy and future directions.
    Fox RI; Fox CM; Gottenberg JE; Dörner T
    Rheumatology (Oxford); 2021 May; 60(5):2066-2074. PubMed ID: 31034046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Biologics in Sjögren's Syndrome.
    Nocturne G; Cornec D; Seror R; Mariette X
    Rheum Dis Clin North Am; 2016 Aug; 42(3):407-17. PubMed ID: 27431344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren's syndrome.
    Carsons SE
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1011-23, x. PubMed ID: 18984419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis.
    Narain S; Berman N; Furie R
    Curr Opin Rheumatol; 2020 Nov; 32(6):609-616. PubMed ID: 33002950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and New Strategies for Primary Sjögren's Syndrome.
    Mavragani CP
    Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present and novel biologic drugs in primary Sjögren's syndrome.
    Fasano S; Isenberg DA
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):167-174. PubMed ID: 31025931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options.
    Birt JA; Tan Y; Mozaffarian N
    Clin Exp Rheumatol; 2017; 35(1):98-107. PubMed ID: 27749234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Monitoring upon Treatment with Biologics in Sjögren's Syndrome: The What, Where, When, and How.
    van Beers JJBC; Damoiseaux JGMC
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33467204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing conventional DMARD therapy for Sjögren's syndrome.
    van der Heijden EHM; Kruize AA; Radstake TRDJ; van Roon JAG
    Autoimmun Rev; 2018 May; 17(5):480-492. PubMed ID: 29526636
    [No Abstract]   [Full Text] [Related]  

  • 11. Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjögren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
    Chen X; Zhang P; Liu Q; Zhang Q; Gu F; Xu S; Körner H; Wu H; Wei W
    Int Immunopharmacol; 2020 Mar; 80():106199. PubMed ID: 31955068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren Syndrome in the Twenty-First Century.
    Scofield RH
    Rheum Dis Clin North Am; 2016 Aug; 42(3):xiii-xiv. PubMed ID: 27431355
    [No Abstract]   [Full Text] [Related]  

  • 13. Sjögren Syndrome: Why Do Clinical Trials Fail?
    Fox RI; Fox CM
    Rheum Dis Clin North Am; 2016 Aug; 42(3):519-30. PubMed ID: 27431352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sjogren's Disease.
    Weisman MH
    Rheum Dis Clin North Am; 2016 Aug; 42(3):xi-xii. PubMed ID: 27431354
    [No Abstract]   [Full Text] [Related]  

  • 15. Biologic treatment in Sjögren's syndrome.
    Sada PR; Isenberg D; Ciurtin C
    Rheumatology (Oxford); 2015 Feb; 54(2):219-30. PubMed ID: 25342375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.
    Carsons SE; Vivino FB; Parke A; Carteron N; Sankar V; Brasington R; Brennan MT; Ehlers W; Fox R; Scofield H; Hammitt KM; Birnbaum J; Kassan S; Mandel S
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):517-527. PubMed ID: 27390247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjögren's syndrome: Old and new therapeutic targets.
    Mavragani CP; Moutsopoulos HM
    J Autoimmun; 2020 Jun; 110():102364. PubMed ID: 31831255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Sjogren's syndrome: current and prospective therapies.
    Thanou-Stavraki A; James JA
    Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Treatment Guidelines for Sjögren's Disease.
    Vivino FB; Carsons SE; Foulks G; Daniels TE; Parke A; Brennan MT; Forstot SL; Scofield RH; Hammitt KM
    Rheum Dis Clin North Am; 2016 Aug; 42(3):531-51. PubMed ID: 27431353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.